To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TTC15TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
430 supporting clones for gene TTC15 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_016030.5   .a 1 to 2524 1 to 2524 exact RefSeq, AAA   2524/2524
(100 %)
0 diff
(100 %id)
CR607934 HeLa cells Cot 25-normalized .a 12 to 2490 1 to 2479   tiling clone,   2479/2479
(100 %)
0 diff
(100 %id)
AL555456 placenta .a 12 to 970 1 to 952       952/952
(100 %)
14 diff
(98.6 %id)
CF594076 Human Placenta, placenta .a 19 to 598 28 to 616       589/1006
(58 %)
24 diff
(97.7 %id)
BG472999 eye, retinoblastoma .a 25 to 663 1 to 641       641/810
(79 %)
23 diff
(97.2 %id)
BF317387 brain, neuroblastoma .a 29 to 756 1 to 713       713/886
(80 %)
25 diff
(97.2 %id)
BI597671 brain, hypothalamus .a 30 to 529 1 to 499       499/499
(100 %)
7 diff
(98.6 %id)
CN399931 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 32 to 526 1 to 495       495/495
(100 %)
2 diff
(99.6 %id)
TI_45213431   .a 35 to 529 125 to 618       494/618
(79 %)
7 diff
(98.9 %id)
BG709041 brain, hypothalamus .a 43 to 811 1 to 764       764/765
(99 %)
14 diff
(98.2 %id)
BI603108 brain, hypothalamus .a 43 to 812 1 to 775       775/776
(99 %)
24 diff
(97.0 %id)
BE255635 eye, retinoblastoma .a 45 to 611 1 to 569       569/708
(80 %)
12 diff
(98.4 %id)
BU963230 mixed (pool of 40 RNAs) .a 45 to 251 1 to 207       207/969
(21 %)
4 diff
(99.6 %id)
BM153767 leukopheresis .a 45 to 620 1 to 576       576/576
(100 %)
6 diff
(99.0 %id)
BX358494 Placenta Cot 25-normalized .a 46 to 561 1 to 513       513/513
(100 %)
5 diff
(99.1 %id)
CR977915 T-Lymphocytes .a 46 to 540 1 to 495       495/497
(99 %)
2 diff
(99.6 %id)
DB502871 hypothalamus .a 48 to 275 1 to 228       228/228
(100 %)
3 diff
(98.7 %id)
TI_45216528   .a 48 to 812 125 to 894       770/895
(86 %)
26 diff
(97.1 %id)
BF315324 brain, neuroblastoma .a 62 to 823 1 to 746       746/924
(80 %)
24 diff
(97.5 %id)
BI828392 brain, medulla .a 64 to 627 1 to 568       568/680
(83 %)
7 diff
(99.0 %id)
TI_57175160   .a 64 to 627 32 to 599       568/711
(79 %)
12 diff
(98.4 %id)
BQ072905 leukocyte .a 66 to 689 1 to 625       625/1069
(58 %)
15 diff
(98.6 %id)
BI547193 brain, hippocampus .a 74 to 719 1 to 646       646/646
(100 %)
3 diff
(99.6 %id)
TI_44167876   .a 75 to 719 73 to 717       645/717
(89 %)
6 diff
(99.2 %id)
DB476591 hippocampus .a 79 to 577 1 to 498       498/503
(99 %)
5 diff
(99.1 %id)
CN399934 embryonic stem cells, cell lines H1, H7, andH9 .a 83 to 710 1 to 629       629/629
(100 %)
7 diff
(98.9 %id)
BG761334 melanotic melanoma, high MDR (cell line), skin .a 89 to 922 1 to 829       829/829
(100 %)
22 diff
(97.4 %id)
BG762555 melanotic melanoma, high MDR (cell line), skin .a 89 to 940 1 to 845       845/893
(94 %)
20 diff
(97.8 %id)
BI457001 epithelioid carcinoma cell line, Pancreas .a 89 to 799 1 to 725       725/854
(84 %)
34 diff
(96.1 %id)
CN399929 embryonic stem cells, cell lines H1, H7, andH9 .a 90 to 724 1 to 635       635/635
(100 %)
2 diff
(99.7 %id)
TI_45133787   .a 90 to 799 61 to 784       724/853
(84 %)
33 diff
(96.2 %id)
CN399933 embryonic stem cells, cell lines H1, H7, andH9 .a 93 to 566 1 to 474       474/474
(100 %)
2 diff
(99.6 %id)
BG677394 skin, squamous cell carcinoma .a 93 to 979 1 to 896       896/896
(100 %)
44 diff
(95.1 %id)
BG259273 embryonal carcinoma, cell line, testis .a 112 to 757 1 to 682       646/1145
(56 %)
45 diff
(96.1 %id)
BF183071 large cell carcinoma, lung .a 123 to 796 1 to 661       661/665
(99 %)
22 diff
(96.7 %id)
BC014164 Lung, large cell carcinoma .a 124 to 2517 1 to 2394   available from MGC, AAA   2394/2394
(100 %)
3 diff
(99.9 %id)
AL557173 T cells (Jurkat cell line), T cells from T cell leukemia .a 124 to 1177 1 to 1044       1044/1044
(100 %)
28 diff
(97.4 %id)
BQ955921 large cell carcinoma, lung .a 124 to 755 81 to 715       635/1026
(61 %)
12 diff
(98.9 %id)
BI116539 lung, small cell carcinoma .a 150 to 777 1 to 627       627/627
(100 %)
14 diff
(97.8 %id)
BE797358 lung, small cell carcinoma .a 170 to 862 1 to 697       697/1143
(60 %)
27 diff
(97.7 %id)
CN399930 embryonic stem cells, cell lines H1, H7, andH9 .a 184 to 796 1 to 613       613/613
(100 %)
1 diff
(99.9 %id)
BQ231179 large cell carcinoma, lung .a 200 to 880 11 to 698       688/941
(73 %)
21 diff
(97.8 %id)
TI_57177118   .a 224 to 968 64 to 807       744/807
(92 %)
6 diff
(99.3 %id)
BI831070 brain, medulla .a 231 to 968 1 to 738       738/738
(100 %)
7 diff
(99.1 %id)
BG325088 Kidney, renal cell adenocarcinoma .a 311 to 1084 1 to 762       762/1052
(72 %)
20 diff
(98.1 %id)
BG420012 Kidney, renal cell adenocarcinoma .a 311 to 1014 1 to 692       692/901
(76 %)
22 diff
(97.6 %id)
DA466713 cord Blood .a 312 to 652 2 to 342   capped   341/341
(100 %)
0 diff
(100 %id)
DA520469 brain .a 314 to 878 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
CN484593 eye .a 353 to 897 1 to 545       545/545
(100 %)
2 diff
(99.7 %id)
BM144302 leukopheresis .a 374 to 737 1 to 365       365/367
(99 %)
4 diff
(99.0 %id)
BE242515 leukopheresis .a 374 to 700 1 to 328       328/328
(100 %)
3 diff
(99.1 %id)
BM144789 leukopheresis .a 374 to 859 1 to 488       488/488
(100 %)
5 diff
(99.0 %id)
BM193650 leukopheresis .a 374 to 852 1 to 479       479/479
(100 %)
1 diff
(99.8 %id)
BM145020 leukopheresis .a 374 to 592 1 to 219       219/223
(98 %)
12 diff
(94.7 %id)
BM145038 leukopheresis .a 374 to 705 1 to 331       331/331
(100 %)
13 diff
(96.1 %id)
BM145094 leukopheresis .a 374 to 506 1 to 133       133/144
(92 %)
8 diff
(94.5 %id)
BM148555 leukopheresis .a 374 to 817 1 to 447       447/447
(100 %)
17 diff
(96.2 %id)
BM145186 leukopheresis .a 374 to 830 1 to 456       456/456
(100 %)
2 diff
(99.6 %id)
BE241925 leukopheresis .a 374 to 586 1 to 213       213/213
(100 %)
3 diff
(98.6 %id)
BE242982 leukopheresis .a 374 to 779 1 to 406       406/406
(100 %)
3 diff
(99.3 %id)
BM148342 leukopheresis .a 374 to 672 1 to 299       299/299
(100 %)
3 diff
(99.0 %id)
BM145291 leukopheresis .a 374 to 780 1 to 407       407/415
(98 %)
10 diff
(97.6 %id)
BM145342 leukopheresis .a 374 to 823 1 to 448       448/450
(99 %)
6 diff
(98.7 %id)
BM145929 leukopheresis .a 374 to 675 1 to 302       302/311
(97 %)
6 diff
(98.1 %id)
BM150519 leukopheresis .a 374 to 930 1 to 558       558/567
(98 %)
5 diff
(99.2 %id)
BM153347 leukopheresis .a 374 to 738 1 to 364       364/377
(96 %)
28 diff
(92.6 %id)
BE243377 leukopheresis .a 374 to 779 1 to 405       405/405
(100 %)
6 diff
(98.6 %id)
BM150825 leukopheresis .a 374 to 663 1 to 289       289/289
(100 %)
10 diff
(96.6 %id)
BM151101 leukopheresis .a 374 to 803 1 to 429       429/429
(100 %)
6 diff
(98.7 %id)
BM151179 leukopheresis .a 374 to 802 1 to 428       428/429
(99 %)
5 diff
(98.9 %id)
BE244983 leukopheresis .a 374 to 675 1 to 302       302/304
(99 %)
2 diff
(99.4 %id)
BE245753 leukopheresis .a 374 to 917 1 to 544       544/544
(100 %)
7 diff
(98.8 %id)
BE245125 leukopheresis .a 374 to 826 1 to 453       453/453
(100 %)
4 diff
(99.2 %id)
BE246557 leukopheresis .a 374 to 830 1 to 456       456/456
(100 %)
6 diff
(98.7 %id)
BE246642 leukopheresis .a 374 to 828 1 to 455       455/455
(100 %)
2 diff
(99.6 %id)
BE247653 leukopheresis .a 374 to 706 1 to 333       333/333
(100 %)
4 diff
(98.8 %id)
BE247150 leukopheresis .a 374 to 630 1 to 256       256/256
(100 %)
7 diff
(97.3 %id)
BM151338 leukopheresis .a 374 to 830 1 to 456       456/456
(100 %)
7 diff
(98.5 %id)
BM153543 leukopheresis .a 374 to 956 1 to 585       585/593
(98 %)
6 diff
(99.0 %id)
BQ232228 embryonal carcinoma, cell line, testis .a 399 to 1190 1 to 797       797/844
(94 %)
12 diff
(98.6 %id)
AA101866 colon, tumor .a 510 to 705 1 to 191       191/191
(100 %)
9 diff
(95.3 %id)
TI_57172193   .a 592 to 1254 62 to 729       668/843
(79 %)
23 diff
(97.3 %id)
BI831530 brain, medulla .a 597 to 1254 1 to 663       663/777
(85 %)
21 diff
(97.3 %id)
DB051641 testis .a 622 to 1179 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
AK094242 cerebellum .a 627 to 2522 1 to 1896   available from FLJ,   1896/1896
(100 %)
5 diff
(99.8 %id)
TI_57173855   .a 640 to 1336 66 to 762       697/764
(91 %)
7 diff
(99.1 %id)
BI825791 brain, medulla .a 646 to 1336 1 to 691       691/693
(99 %)
3 diff
(99.6 %id)
DB084232 testis .a 659 to 1230 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
DB027642 testis .a 664 to 1057 2 to 395   capped   394/394
(100 %)
1 diff
(99.8 %id)
DB066183 testis .a 664 to 1021 2 to 359   capped   358/358
(100 %)
1 diff
(99.8 %id)
BU844732 ovary, teratocarcinoma, cell line .a 668 to 1258 20 to 612       593/924
(64 %)
30 diff
(96.8 %id)
DA455288 tongue, tumor tissue .a 669 to 1139 2 to 472   capped   471/471
(100 %)
0 diff
(100 %id)
DB059993 testis .a 684 to 1213 2 to 532   capped   531/531
(100 %)
1 diff
(99.9 %id)
BG421813 Kidney, renal cell adenocarcinoma .a 685 to 1370 1 to 684       684/693
(98 %)
6 diff
(99.2 %id)
DB043889 testis .a 721 to 1293 2 to 576   capped   575/575
(100 %)
3 diff
(99.5 %id)
BM564636 duodenal adenocarcinoma, cell line, small intestine .a 728 to 1486 1 to 760       760/1068
(71 %)
10 diff
(99.1 %id)
DB056920 testis .a 740 to 1279 2 to 542   capped   541/541
(100 %)
3 diff
(99.5 %id)
CD557498 testis .a 746 to 1616 26 to 901       876/902
(97 %)
20 diff
(97.8 %id)
CD359348 testis .a 768 to 1600 1 to 837       837/888
(94 %)
14 diff
(98.5 %id)
BX370474   .a 769 to 1370 1 to 601       601/601
(100 %)
4 diff
(99.4 %id)
BX391955   .a 792 to 1726 932 to 1       932/932
(100 %)
17 diff
(98.2 %id)
DB190063 lung, tumor tissue .a 802 to 1372 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
AL522917 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 844 to 1662 1 to 823   fully sequenced,   823/823
(100 %)
11 diff
(98.7 %id)
CB154411 brain .a 909 to 1529 1 to 621       621/621
(100 %)
0 diff
(100 %id)
BF529609 anaplastic oligodendroglioma with 1p/19qloss, brain .a 927 to 1572 1 to 643       643/643
(100 %)
3 diff
(99.6 %id)
BC017475 Muscle, rhabdomyosarcoma .a 1003 to 2517 1 to 1515   available from MGC, AAA   1515/1515
(100 %)
1 diff
(100.0 %id)
BE297251 muscle, rhabdomyosarcoma .a 1022 to 1656 1 to 631   available from MGC,   631/633
(99 %)
4 diff
(99.4 %id)
BX362884   .a 1040 to 1971 32 to 960       929/969
(95 %)
14 diff
(98.6 %id)
CX762143 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1061 to 1778 1 to 718     Submitted on the opposite strand 718/718
(100 %)
1 diff
(99.9 %id)
BE720217 head_neck .a 1154 to 1749 1 to 593       593/613
(96 %)
14 diff
(97.8 %id)
BE720216 head_neck .a 1160 to 1749 1 to 587       587/595
(98 %)
15 diff
(97.5 %id)
BM789043 Ascites, stomach .a 1211 to 1747 1 to 537       537/537
(100 %)
0 diff
(100 %id)
BG769769 melanotic melanoma, high MDR (cell line), skin .a 1212 to 2011 1 to 798       798/798
(100 %)
6 diff
(99.3 %id)
BU783652 insulinoma, Pancreas .a 1219 to 1826 1 to 608       608/608
(100 %)
3 diff
(99.6 %id)
CK902605 insulinoma, Pancreas .a 1219 to 1793 1 to 575       575/575
(100 %)
8 diff
(98.7 %id)
CU450352 epidermis .a 1228 to 1785 1 to 558       558/558
(100 %)
9 diff
(98.4 %id)
AW796843 uterus .a 1251 to 1618 10 to 378       369/378
(97 %)
10 diff
(97.4 %id)
BE272169 adenocarcinoma cell line, ovary .a 1253 to 1882 29 to 655       627/655
(95 %)
7 diff
(99.0 %id)
BM014882 breast, mammary adenocarcinoma, cell line .a 1253 to 2056 1 to 803       800/803
(99 %)
9 diff
(98.9 %id)
TI_59392961   .a 1253 to 2056 91 to 893       800/803
(99 %)
9 diff
(98.9 %id)
BF968496 adrenal cortex carcinoma, cell line, adrenal gland .a 1254 to 1982 11 to 735       725/944
(76 %)
14 diff
(98.6 %id)
CX870736 embryonic stem .a 1261 to 2099 1 to 839       839/839
(100 %)
0 diff
(100 %id)
TI_1948093391   .a 1266 to 1980 122 to 841       720/1450
(49 %)
31 diff
(97.9 %id)
AA334708   .a 1271 to 1538 1 to 268       268/268
(100 %)
0 diff
(100 %id)
AF151845   .a 1272 to 2524 1 to 1253       1253/1258
(99 %)
7 diff
(99.5 %id)
AA129460 lung, lung carcinoma .a 1273 to 1516 10 to 259       250/261
(95 %)
13 diff
(95.1 %id)
CV028112 mixed .a 1275 to 1946 1 to 672       672/673
(99 %)
7 diff
(99.0 %id)
AL120746 melanoma (MeWo cell line) .a 1277 to 1767 1 to 491   fully sequenced,   491/491
(100 %)
0 diff
(100 %id)
DA766463 tongue .a 1281 to 1795 2 to 517   capped   516/516
(100 %)
1 diff
(99.9 %id)
R35109 whole brain .a 1294 to 1745 1 to 457       457/484
(94 %)
22 diff
(95.5 %id)
AW629889 2 pooled high-grade transitional celltumors, genitourinary tract .a 1314 to 1731 1 to 418       418/418
(100 %)
6 diff
(98.6 %id)
BF833240 head_neck .a 1320 to 1677 1 to 361       359/446
(80 %)
16 diff
(96.5 %id)
BF833452 head_neck .a 1320 to 1677 1 to 361       359/446
(80 %)
16 diff
(96.5 %id)
BG481170 choriocarcinoma, placenta .a 1357 to 2150 1 to 799       799/958
(83 %)
10 diff
(99.0 %id)
BE903295 choriocarcinoma, placenta .a 1371 to 1982 82 to 691       610/1048
(58 %)
11 diff
(99.0 %id)
BG260638 bladder, transitional cell papilloma, cell line .a 1371 to 2064 9 to 702       694/988
(70 %)
21 diff
(97.9 %id)
AL579263 T cells (Jurkat cell line), T cells from T cell leukemia .a 1373 to 2493 1014 to 1       844/1014
(83 %)
59 diff
(94.2 %id)
AA324440 brain, cerebellum .a 1406 to 1826 1 to 428       428/428
(100 %)
7 diff
(98.4 %id)
BF794000 adrenal cortex carcinoma, cell line, adrenal gland .a 1447 to 2172 13 to 741       729/918
(79 %)
20 diff
(97.9 %id)
BG254805 adenocarcinoma, cell line, Prostate .a 1447 to 2228 13 to 793       781/976
(80 %)
19 diff
(98.1 %id)
CU452843 epidermis .a 1449 to 2083 641 to 6     Submitted on the opposite strand 636/641
(99 %)
1 diff
(99.9 %id)
CU451014 epidermis .a 1464 to 2083 626 to 6     Submitted on the opposite strand 621/626
(99 %)
0 diff
(100 %id)
BM020509 astrocytoma grade IV, cell line, brain .a 1470 to 2306 1 to 834       834/835
(99 %)
16 diff
(98.1 %id)
TI_59391297   .a 1471 to 2306 99 to 931       833/834
(99 %)
15 diff
(98.3 %id)
CU456701 epidermis .a 1476 to 2083 614 to 6     Submitted on the opposite strand 609/614
(99 %)
0 diff
(100 %id)
AL577956 placenta .a 1490 to 2490 999 to 1       999/999
(100 %)
18 diff
(98.2 %id)
CN399935 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1497 to 1977 1 to 479       479/479
(100 %)
7 diff
(98.6 %id)
CX761122 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1513 to 2237 1 to 725     Submitted on the opposite strand 725/725
(100 %)
2 diff
(99.8 %id)
BE543592 cervical carcinoma cell line, cervix .a 1533 to 2320 1 to 805       716/806
(88 %)
32 diff
(96.1 %id)
CU455581 epidermis .a 1534 to 2083 556 to 6     Submitted on the opposite strand 551/556
(99 %)
2 diff
(99.7 %id)
CU450235 epidermis .a 1557 to 2083 533 to 6     Submitted on the opposite strand 528/533
(99 %)
0 diff
(100 %id)
BM149876 leukopheresis .a 1590 to 2151 562 to 1       562/562
(100 %)
0 diff
(100 %id)
BM148797 leukopheresis .a 1598 to 2151 554 to 1       554/555
(99 %)
1 diff
(99.9 %id)
BE244419 leukopheresis .a 1608 to 2151 544 to 1       544/544
(100 %)
1 diff
(99.9 %id)
BM194258 leukopheresis .a 1615 to 2151 537 to 1       537/538
(99 %)
1 diff
(99.9 %id)
BM452182 melanotic melanoma, skin .a 1616 to 2523 1 to 908   AAA   908/908
(100 %)
13 diff
(98.6 %id)
BM146428 leukopheresis .a 1623 to 2151 526 to 1       526/529
(99 %)
8 diff
(98.5 %id)
BM146116 leukopheresis .a 1629 to 2151 523 to 1       523/524
(99 %)
23 diff
(95.7 %id)
AL562140 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 1639 to 2457 837 to 19   fully sequenced,   819/837
(97 %)
24 diff
(97.2 %id)
BM153136 leukopheresis .a 1647 to 2151 504 to 1       504/504
(100 %)
5 diff
(99.1 %id)
BE245182 leukopheresis .a 1656 to 2151 496 to 1       496/496
(100 %)
1 diff
(99.8 %id)
BM194085 leukopheresis .a 1658 to 2151 494 to 1       494/494
(100 %)
0 diff
(100 %id)
TI_149301678   .a 1670 to 2517 922 to 87   AAA   836/967
(86 %)
17 diff
(98.3 %id)
BM147622 leukopheresis .a 1672 to 2151 479 to 1       479/479
(100 %)
10 diff
(98.0 %id)
AA339557 brain .a 1676 to 2058 1 to 384       384/384
(100 %)
6 diff
(98.5 %id)
BM146436 leukopheresis .a 1676 to 2151 475 to 1       475/475
(100 %)
6 diff
(98.8 %id)
AA244194   .a 1689 to 2075 9 to 396       388/396
(97 %)
9 diff
(97.8 %id)
BQ954367 large cell carcinoma, lung .a 1689 to 2511 1 to 831   AAA   831/896
(92 %)
22 diff
(97.6 %id)
BE244953 leukopheresis .a 1701 to 2151 451 to 1       451/451
(100 %)
11 diff
(97.6 %id)
AL120747 melanoma (MeWo cell line) .a 1706 to 1964 260 to 1   fully sequenced,   260/260
(100 %)
0 diff
(100 %id)
BM148208 leukopheresis .a 1710 to 2151 442 to 1       442/442
(100 %)
2 diff
(99.6 %id)
BE243858 leukopheresis .a 1719 to 2151 433 to 1       433/433
(100 %)
1 diff
(99.8 %id)
BF895795 marrow .a 1728 to 2169 446 to 4     Submitted on the opposite strand 443/455
(97 %)
11 diff
(97.6 %id)
CN399932 embryonic stem cells, DMSO-treated H9 cellline .a 1728 to 2335 1 to 608       608/608
(100 %)
3 diff
(99.6 %id)
TI_149297399   .a 1728 to 2517 845 to 58   AAA   788/964
(81 %)
9 diff
(99.1 %id)
BM194248 leukopheresis .a 1735 to 2151 417 to 1       417/456
(91 %)
6 diff
(98.7 %id)
CA431073 cell lines, Chondrosarcoma .a 1751 to 2517 784 to 19   AAA   766/766
(100 %)
1 diff
(99.9 %id)
BU633464 cell lines, Chondrosarcoma .a 1759 to 2517 777 to 19   AAA   759/763
(99 %)
2 diff
(99.8 %id)
BE246315 leukopheresis .a 1762 to 2151 390 to 1       390/390
(100 %)
1 diff
(99.8 %id)
BM982471 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1766 to 2517 770 to 19   AAA   752/752
(100 %)
0 diff
(100 %id)
BM705821 eye, lens .a 1767 to 2240 1 to 474       474/474
(100 %)
1 diff
(99.8 %id)
BM712225 eye, lens .a 1774 to 2114 1 to 341   fully sequenced,   341/341
(100 %)
0 diff
(100 %id)
BG910271 anaplastic oligodendroglioma with 1p/19qloss, brain .a 1778 to 2340 1 to 564       564/564
(100 %)
2 diff
(99.7 %id)
BE242172 leukopheresis .a 1787 to 2151 365 to 1       365/365
(100 %)
0 diff
(100 %id)
BM146393 leukopheresis .a 1798 to 2151 354 to 1       354/357
(99 %)
3 diff
(99.2 %id)
BM194289 leukopheresis .a 1804 to 2151 348 to 1       348/384
(90 %)
11 diff
(97.2 %id)
BM193899 leukopheresis .a 1810 to 2151 345 to 1       345/345
(100 %)
4 diff
(98.9 %id)
CD368427 Alveolar Macrophage, lung .a 1821 to 2517 715 to 19   AAA   697/697
(100 %)
2 diff
(99.8 %id)
BQ002780 Chondrosarcoma, Left Pelvis .a 1825 to 2517 711 to 19   AAA   693/693
(100 %)
1 diff
(99.9 %id)
BU685236 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 1827 to 2517 708 to 19   AAA   690/690
(100 %)
1 diff
(99.9 %id)
BU733669 eye, Retina Foveal and Macular .a 1833 to 2517 703 to 19   AAA   685/695
(98 %)
1 diff
(99.9 %id)
BE242875 leukopheresis .a 1840 to 2151 312 to 1       312/312
(100 %)
2 diff
(99.4 %id)
CA426768 cell lines, Chondrosarcoma .a 1842 to 2517 694 to 19   AAA   676/676
(100 %)
1 diff
(99.9 %id)
BE246782 leukopheresis .a 1843 to 2151 309 to 1       309/309
(100 %)
7 diff
(97.8 %id)
BQ017253 lung, Metastatic Chondrosarcoma .a 1848 to 2517 688 to 19   AAA   670/670
(100 %)
5 diff
(99.3 %id)
BM149186 leukopheresis .a 1876 to 2151 276 to 1       276/343
(80 %)
12 diff
(96.6 %id)
TI_149280397   .a 1882 to 2523 726 to 85   AAA   642/717
(89 %)
5 diff
(99.4 %id)
TI_151770875   .a 1882 to 2511 197 to 836       640/836
(76 %)
15 diff
(98.3 %id)
BM152228 leukopheresis .a 1884 to 2151 268 to 1       268/268
(100 %)
3 diff
(98.9 %id)
BU782660 insulinoma, Pancreas .a 1887 to 2524 654 to 17   tiling clone, AAA   638/638
(100 %)
0 diff
(100 %id)
BM988214 mixed .a 1892 to 2517 643 to 19   AAA   625/625
(100 %)
3 diff
(99.6 %id)
AA569672   .a 1901 to 2313 1 to 414       414/414
(100 %)
10 diff
(97.6 %id)
BM152641 leukopheresis .a 1905 to 2151 247 to 1       247/247
(100 %)
7 diff
(97.2 %id)
BU679186 lung, Primary Lung Epithelial Cells .a 1905 to 2523 637 to 19   AAA   619/619
(100 %)
3 diff
(99.6 %id)
BF929240 nervous_tumor .a 1907 to 2344 1 to 438       438/438
(100 %)
8 diff
(98.2 %id)
BF928163 nervous_tumor .a 1910 to 2163 262 to 10     Submitted on the opposite strand 253/262
(96 %)
6 diff
(97.8 %id)
BI334575 cervical carcinoma cell line, cervix .a 1912 to 2518 615 to 9     Submitted on the opposite strand 607/617
(98 %)
1 diff
(99.9 %id)
BX358493 Placenta Cot 25-normalized .a 1917 to 2456 535 to 1       535/535
(100 %)
15 diff
(97.2 %id)
BE242652 leukopheresis .a 1932 to 2151 220 to 1       220/220
(100 %)
4 diff
(98.2 %id)
FN050717 breast carcinoma .a 1985 to 2097 1 to 113       113/113
(100 %)
1 diff
(99.2 %id)
AW300899 colon, moderately differentiated adenocarcinoma .a 1986 to 2524 570 to 32   AAA   539/539
(100 %)
1 diff
(99.9 %id)
BE242812 leukopheresis .a 1992 to 2151 158 to 1       158/158
(100 %)
5 diff
(96.9 %id)
AW613411 2 pooled high-grade transitional celltumors, genitourinary tract .a 1997 to 2397 402 to 1       402/448
(89 %)
21 diff
(95.4 %id)
AI652660 pooled germ cell tumors .a 1999 to 2518 525 to 6       520/525
(99 %)
1 diff
(99.9 %id)
AW167744 cervix .a 2000 to 2516 519 to 1       469/519
(90 %)
48 diff
(90.8 %id)
CA313788 Human Lung Epithelial cells, lung .a 2008 to 2517 528 to 19   AAA   510/516
(98 %)
1 diff
(99.9 %id)
AA436513 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2009 to 2434 1 to 419       419/419
(100 %)
6 diff
(98.6 %id)
BI333583 cervical carcinoma cell line, cervix .a 2009 to 2517 1 to 509   AAA   509/509
(100 %)
1 diff
(99.9 %id)
AA569649   .a 2017 to 2430 1 to 414       414/414
(100 %)
4 diff
(99.1 %id)
BP391804 pancreatic islet .a 2019 to 2517 1 to 499     Submitted on the opposite strand 499/499
(100 %)
0 diff
(100 %id)
W79935 heart .a 2035 to 2202 1 to 171   fully sequenced,   171/171
(100 %)
0 diff
(100 %id)
BE221131 malignant melanoma, metastatic to lymphnode, skin .a 2043 to 2517 497 to 23   AAA   475/475
(100 %)
9 diff
(98.2 %id)
BM695449 eye, optic nerve .a 2048 to 2523 1 to 476   fully sequenced, AAA   476/476
(100 %)
1 diff
(99.8 %id)
BU737694 eye, lens .a 2053 to 2517 483 to 19   fully sequenced, AAA   465/465
(100 %)
0 diff
(100 %id)
AI203708   .a 2071 to 2517 462 to 16   AAA   447/447
(100 %)
1 diff
(99.8 %id)
DB574062 hypothalamus .a 2073 to 2517 5 to 449     Submitted on the opposite strand 445/449
(99 %)
6 diff
(98.7 %id)
BX330991   .a 2074 to 2510 447 to 12       436/519
(84 %)
14 diff
(97.4 %id)
AA716407 heart .a 2076 to 2517 440 to 1       440/441
(99 %)
13 diff
(97.1 %id)
AA131340   .a 2080 to 2517 459 to 24   AAA   436/440
(99 %)
10 diff
(97.8 %id)
W27763 eye, retina .a 2086 to 2511 452 to 21       432/497
(86 %)
8 diff
(98.4 %id)
DB553453 hypothalamus .a 2088 to 2517 1 to 430     Submitted on the opposite strand 430/430
(100 %)
4 diff
(99.1 %id)
AI056797 liver and spleen .a 2093 to 2518 426 to 1       426/426
(100 %)
1 diff
(99.8 %id)
AW572079 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2095 to 2518 425 to 2       424/425
(99 %)
0 diff
(100 %id)
AA677278 liver and spleen .a 2103 to 2517 413 to 1       413/415
(99 %)
6 diff
(98.6 %id)
AW057743 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2106 to 2524 422 to 4       419/422
(99 %)
0 diff
(100 %id)
AI032915 liver and spleen .a 2107 to 2518 403 to 1       403/405
(99 %)
18 diff
(95.6 %id)
AI582819 anaplastic oligodendroglioma, brain .a 2107 to 2517 423 to 13   AAA   411/411
(100 %)
1 diff
(99.8 %id)
EL952250 eyeball .a 2112 to 2517 36 to 440   AAA   405/440
(92 %)
8 diff
(98.2 %id)
DW441890 Liver .a 2114 to 2333 17 to 236       220/236
(93 %)
6 diff
(97.5 %id)
AI208439   .a 2115 to 2518 412 to 8       405/412
(98 %)
0 diff
(100 %id)
BM665794 eye, Retina Foveal and Macular .a 2118 to 2517 418 to 19   AAA   400/405
(98 %)
2 diff
(99.6 %id)
AI096486 brain, glioblastoma (pooled) .a 2119 to 2517 414 to 16   AAA   399/399
(100 %)
0 diff
(100 %id)
AI609750 brain, glioblastoma (pooled) .a 2119 to 2517 413 to 15   AAA   399/399
(100 %)
2 diff
(99.5 %id)
AA490824 germinal center B cell .a 2121 to 2524 420 to 18   AAA   403/403
(100 %)
3 diff
(99.3 %id)
AW074046 2 pooled high-grade transitional celltumors, genitourinary tract .a 2123 to 2524 415 to 14   AAA   402/402
(100 %)
1 diff
(99.8 %id)
AA626327   .a 2129 to 2524 399 to 6       394/399
(98 %)
0 diff
(100 %id)
W78110 heart .a 2141 to 2517 399 to 22   fully sequenced, AAA   378/378
(100 %)
8 diff
(97.9 %id)
BU728873 eye, optic nerve .a 2141 to 2523 401 to 19   fully sequenced, AAA   383/383
(100 %)
0 diff
(100 %id)
AI084144 anaplastic oligodendroglioma, brain .a 2145 to 2517 385 to 13   AAA   373/373
(100 %)
1 diff
(99.8 %id)
AA723727 pooled .a 2151 to 2524 375 to 5       371/375
(98 %)
0 diff
(100 %id)
F25694 pectoral muscle (after mastectomy) .a 2151 to 2385 1 to 237       237/237
(100 %)
3 diff
(98.8 %id)
AI753217 bone marrow stroma .a 2158 to 2517 378 to 19   AAA   360/360
(100 %)
0 diff
(100 %id)
AJ572359 pectoral muscle (after mastectomy) .a 2159 to 2261 1 to 107       107/118
(90 %)
3 diff
(97.5 %id)
R49497 whole brain .a 2242 to 2516 288 to 12   AAA   277/278
(99 %)
9 diff
(96.8 %id)
AK094181   .b 1 to 2556 2 to 2506 R41L T78Q P79G A80L P81L ... tiling clone, available from FLJ, Suspected internal deletion 2506/2506
(100 %)
7 diff
(99.8 %id)
AK098327 uterus .c 1 to 2483 2 to 2484 exact tiling clone, available from FLJ,   2484/2484
(100 %)
3 diff
(99.9 %id)
DB260548 uterus .c 1 to 552 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
BX332798 Neuroblastoma Cot 25-normalized .c 47 to 974 1 to 922       922/925
(99 %)
10 diff
(99.0 %id)
BU171704 melanotic melanoma, skin .c 96 to 683 1 to 593       593/975
(60 %)
13 diff
(98.7 %id)
BX332797 Neuroblastoma Cot 25-normalized .c 1466 to 2448 980 to 1       980/980
(100 %)
9 diff
(99.1 %id)
AI423068 brain, glioblastoma (pooled) .c 2135 to 2482 353 to 6       348/355
(98 %)
0 diff
(100 %id)
BE044814 follicular adenoma (benign lesion), thyroid .c 2135 to 2452 52 to 369     Submitted on the opposite strand 318/369
(86 %)
6 diff
(98.4 %id)
AA431957   .c 2136 to 2481 375 to 32   AAA   344/344
(100 %)
3 diff
(99.2 %id)
AA642228 invasive tumor (cell line), Prostate .c 2136 to 2385 250 to 1       250/259
(96 %)
3 diff
(98.9 %id)
AA740620 germinal center B cell .c 2136 to 2447 309 to 1       309/309
(100 %)
6 diff
(98.1 %id)
C00729   .c 2138 to 2381 21 to 264       244/265
(92 %)
4 diff
(98.5 %id)
AW079414 colon, moderately differentiated adenocarcinoma .c 2140 to 2482 342 to 1       342/342
(100 %)
1 diff
(99.8 %id)
AI886757 lymph node, lymphoma, follicular mixed small and largecell .c 2142 to 2482 342 to 2       341/342
(99 %)
0 diff
(100 %id)
AI869581 anaplastic oligodendroglioma, brain .c 2142 to 2482 344 to 4       341/344
(99 %)
0 diff
(100 %id)
DB512849 testis .c 2146 to 2481 1 to 334     Submitted on the opposite strand 334/334
(100 %)
9 diff
(97.4 %id)
BF592584 breast, lobullar carcinoma in situ .c 2150 to 2375 1 to 226     Submitted on the opposite strand 226/226
(100 %)
12 diff
(94.7 %id)
AI682403 Prostate .c 2152 to 2482 333 to 3       331/334
(99 %)
0 diff
(100 %id)
AI004337   .c 2153 to 2488 339 to 4   tiling clone,   336/339
(99 %)
0 diff
(100 %id)
AI656957 pooled germ cell tumors .c 2158 to 2488 332 to 2       331/332
(99 %)
0 diff
(100 %id)
AI864899 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 2159 to 2482 325 to 2       324/325
(99 %)
0 diff
(100 %id)
AW732243 lung, small cell carcinoma .c 2174 to 2482 313 to 5       309/313
(98 %)
0 diff
(100 %id)
BF588823 breast, lobullar carcinoma in situ .c 2175 to 2426 1 to 252     Submitted on the opposite strand 252/258
(97 %)
2 diff
(99.3 %id)
BF591758 breast, lobullar carcinoma in situ .c 2180 to 2375 1 to 196     Submitted on the opposite strand 196/196
(100 %)
3 diff
(98.5 %id)
BE243424 leukopheresis .c 2189 to 2479 293 to 3       291/293
(99 %)
0 diff
(100 %id)
AA719083 pineal gland .c 2212 to 2482 271 to 2       270/271
(99 %)
0 diff
(100 %id)
T03781   .c 2217 to 2481 266 to 1       266/275
(96 %)
4 diff
(98.6 %id)
T35337 prostate gland .c 2221 to 2482 1 to 262       262/264
(99 %)
1 diff
(99.7 %id)
EC543100 Prostate .c 2223 to 2312 1 to 92       92/92
(100 %)
2 diff
(97.9 %id)
AI038540   .c 2239 to 2487 252 to 6       247/252
(98 %)
0 diff
(100 %id)
BF197941 skin, normal, 4 pooled samples .c 2244 to 2482 240 to 2       239/240
(99 %)
0 diff
(100 %id)
BF913014 uterus_tumor .c 2248 to 2396 19 to 167       149/167
(89 %)
6 diff
(96.5 %id)
BQ371050 prostate_normal .c 2260 to 2404 151 to 9       143/157
(91 %)
0 diff
(100 %id)
BF913018 uterus_tumor .c 2264 to 2393 130 to 3     Submitted on the opposite strand 128/130
(98 %)
0 diff
(100 %id)
AA244268   .c 2287 to 2488 202 to 2       201/202
(99 %)
0 diff
(100 %id)
AA719165   .c 2325 to 2488 167 to 4       164/167
(98 %)
0 diff
(100 %id)
AW009036 colon .c 2340 to 2482 144 to 2       143/144
(99 %)
0 diff
(100 %id)
AA908432 ovary, serous adenocarcinoma .c 2393 to 2481 103 to 15   AAA   89/89
(100 %)
0 diff
(100 %id)
AA826538 carcinoid, lung .c 2394 to 2481 88 to 1       88/88
(100 %)
0 diff
(100 %id)
AA355232   .c 2400 to 2715 1 to 315   tiling clone,   315/315
(100 %)
5 diff
(98.5 %id)
DA031172   .d 1 to 603 2 to 553   tiling clone, capped Suspected internal deletion 552/552
(100 %)
1 diff
(99.9 %id)
DB295796   .d 2003 to 2538 536 to 1   tiling clone, Suspected internal deletion 536/536
(100 %)
2 diff
(99.7 %id)
DA057546 cerebellum .e 1 to 556 2 to 557   tiling clone, capped   556/556
(100 %)
1 diff
(99.9 %id)
DB296709 cerebellum .e 1353 to 1895 544 to 1   tiling clone,   544/546
(99 %)
4 diff
(99.3 %id)
CR610194 placenta .f 1 to 1538 1 to 1538 exact tiling clone,   1538/1538
(100 %)
0 diff
(100 %id)
BX417288 placenta .f 1 to 850 1 to 844   fully sequenced,   844/844
(100 %)
11 diff
(98.7 %id)
BX412197 placenta .f 820 to 1538 721 to 1   fully sequenced,   721/721
(100 %)
8 diff
(98.9 %id)
CV400841 marrow .f 1183 to 1692 21 to 530       510/530
(96 %)
6 diff
(98.9 %id)
AA327381 colon .f 1324 to 1529 4 to 209       206/209
(98 %)
6 diff
(97.2 %id)
BI825935 brain, medulla .f 1357 to 2130 777 to 1   tiling clone, Submitted on the opposite strand 777/777
(100 %)
6 diff
(99.3 %id)
TI_57173776   .f 1357 to 2130 805 to 29     Submitted on the opposite strand 777/805
(96 %)
0 diff
(100 %id)
DB516043 testis .f 1576 to 2020 445 to 1       445/445
(100 %)
0 diff
(100 %id)
DB450588 testis .f 1685 to 2120 436 to 1   tiling clone, Submitted on the opposite strand 436/436
(100 %)
0 diff
(100 %id)
DB151860 thymus .g 1 to 522 2 to 525   tiling clone, to resequence, capped   524/524
(100 %)
2 diff
(99.7 %id)
DB346194 thymus .g 1260 to 1799 540 to 1   tiling clone, to resequence,   540/540
(100 %)
0 diff
(100 %id)
BG721620 testis .h 1 to 688 1 to 688   tiling clone,   688/688
(100 %)
5 diff
(99.3 %id)
DB461179 testis .h 6 to 492 1 to 487       487/487
(100 %)
0 diff
(100 %id)
CD359217 testis .h 23 to 271 1 to 250       250/258
(96 %)
3 diff
(98.9 %id)
BM147660 leukopheresis .h 667 to 1227 563 to 1   tiling clone,   563/563
(100 %)
2 diff
(99.7 %id)
TI_57176123   .i 1 to 716 29 to 746   tiling clone,   718/746
(96 %)
8 diff
(99.0 %id)
BI829206 brain, medulla .i 2 to 716 1 to 717   tiling clone,   717/717
(100 %)
3 diff
(99.6 %id)
DB526595 testis .i 638 to 1091 1 to 454   tiling clone, Submitted on the opposite strand 454/455
(99 %)
1 diff
(99.8 %id)
BF851699 lung_normal .i 825 to 1039 17 to 230       214/230
(93 %)
7 diff
(97.0 %id)
AW889156 nervous_tumor .i 1025 to 1419 16 to 411   tiling clone,   396/411
(96 %)
6 diff
(98.6 %id)
BM832406 stomach .j 1 to 374 1 to 375       375/383
(97 %)
3 diff
(99.3 %id)
BM833399 stomach .j 1 to 408 1 to 408       408/408
(100 %)
0 diff
(100 %id)
BM833464 stomach .j 1 to 448 1 to 448   tiling clone,   448/448
(100 %)
0 diff
(100 %id)
BM834803 stomach .j 2 to 420 1 to 419       419/419
(100 %)
0 diff
(100 %id)
CA313213 Human Lung Epithelial cells, lung .j 195 to 815 639 to 19   tiling clone, AAA   621/621
(100 %)
10 diff
(98.4 %id)
AW117671 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .j 265 to 809 552 to 8       545/582
(93 %)
14 diff
(97.6 %id)
BG194603   .j 268 to 809 1 to 544       544/546
(99 %)
12 diff
(97.9 %id)
BG196614   .j 269 to 813 1 to 548   AAA   548/548
(100 %)
12 diff
(97.9 %id)
BG217541   .j 270 to 813 1 to 546       546/578
(94 %)
39 diff
(93.3 %id)
BG199708   .j 274 to 792 7 to 524       518/820
(63 %)
43 diff
(94.8 %id)
BG216362   .j 274 to 807 8 to 544   tiling clone,   537/578
(92 %)
9 diff
(98.5 %id)
AK125105 tongue, tumor tissue .k 1 to 3398 2 to 3397 exact tiling clone, available from FLJ,   3397/3397
(100 %)
5 diff
(99.9 %id)
DA455824 tongue, tumor tissue .k 1 to 540 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
FN114179 breast carcinoma .k 2388 to 2472 1 to 87       87/87
(100 %)
4 diff
(95.5 %id)
BY799151 eye .l-u 1 to 600 1 to 600   tiling clone,   600/600
(100 %)
0 diff
(100 %id)
BG287357 bladder, transitional cell papilloma, cell line .l-u 473 to 1208 1 to 772   tiling clone,   772/1097
(70 %)
38 diff
(96.6 %id)
BQ291588 amnion_normal .l-u 584 to 902 320 to 1   tiling clone,   320/320
(100 %)
6 diff
(98.2 %id)
AL390132 brain .l-u 656 to 2268 1 to 1613   tiling clone, available from DKFZ, AAA   1613/1613
(100 %)
0 diff
(100 %id)
CF139604 CNCAP(3)T-225 cell line, Prostate .l-u 980 to 1423 1 to 444       444/444
(100 %)
7 diff
(98.5 %id)
TI_154169837   .l-u 987 to 1575 88 to 681       594/1050
(56 %)
27 diff
(97.5 %id)
DR001369 fetal brain .l-u 1199 to 1917 8 to 725       718/725
(99 %)
3 diff
(99.6 %id)
BX108252 liver and spleen .l-u 1299 to 2027 1 to 729       729/729
(100 %)
5 diff
(99.4 %id)
W04494 liver and spleen .l-u 1299 to 1723 1 to 413       413/418
(98 %)
13 diff
(96.9 %id)
BF058523 fibrotheoma, ovary .l-u 1527 to 1939 1 to 413     Submitted on the opposite strand 413/413
(100 %)
4 diff
(99.1 %id)
BM701857 eye, optic nerve .l-u 1571 to 2161 1 to 591       591/591
(100 %)
0 diff
(100 %id)
AI793312.
matches multiple genes
carcinoid, lung .l-u 1677 to 2198 1 to 522     also hits gene porkawbu 522/522
(100 %)
2 diff
(99.7 %id)
TI_57184062   .l-u 1696 to 2269 24 to 594   AAA   571/594
(96 %)
6 diff
(99.0 %id)
BC035567 Lung, Spleen, fetal, pooled .l-u 1702 to 2268 1 to 567   available from MGC, AAA   567/567
(100 %)
1 diff
(99.9 %id)
BI770698 pooled lung and spleen .l-u 1702 to 2269 1 to 565   available from MGC, AAA   565/565
(100 %)
6 diff
(99.0 %id)
CA440343 lung, Lung Focal Fibrosis .l-u 1712 to 2268 575 to 19   AAA   557/557
(100 %)
1 diff
(99.9 %id)
AI804923 Prostate .l-u 1768 to 2270 503 to 1   tiling clone,   503/503
(100 %)
0 diff
(100 %id)
AI992261 anaplastic oligodendroglioma, brain .l-u 1769 to 2270 509 to 8       502/509
(98 %)
0 diff
(100 %id)
AW140138   .l-u 1776 to 2268 510 to 18   AAA   493/493
(100 %)
2 diff
(99.6 %id)
N70274 liver and spleen .l-u 1812 to 2270 463 to 3       461/463
(99 %)
0 diff
(100 %id)
AW770613 carcinoid, lung .l-u 1826 to 2270 451 to 7       445/451
(98 %)
0 diff
(100 %id)
W88993 liver and spleen .l-u 1844 to 2262 430 to 1       430/430
(100 %)
10 diff
(97.7 %id)
AA934526 carcinoid, lung .l-u 1865 to 2270 407 to 2       406/407
(99 %)
0 diff
(100 %id)
AI077351 B-cell, chronic lymphotic leukemia .l-u 1983 to 2270 291 to 4       288/291
(98 %)
0 diff
(100 %id)
BE246409 leukopheresis .l-u 1984 to 2268 286 to 1       286/287
(99 %)
14 diff
(95.2 %id)
CD359567 testis .m 1 to 756 1 to 756 S133G tiling clone,   756/854
(88 %)
10 diff
(98.9 %id)
TI_57170215   .n 1 to 632 18 to 650   tiling clone,   633/650
(97 %)
6 diff
(99.1 %id)
BI825168 brain, medulla .n 20 to 632 1 to 613       613/613
(100 %)
0 diff
(100 %id)
AW813516 stomach .n 127 to 662 539 to 1   tiling clone,   539/539
(100 %)
4 diff
(99.3 %id)
AA448088   .n 446 to 865 1 to 419   tiling clone,   419/419
(100 %)
1 diff
(99.8 %id)
AA084462 pineal gland .n 565 to 727 1 to 163       163/163
(100 %)
2 diff
(98.8 %id)
AA447589   .n 1162 to 1509 350 to 5   tiling clone,   346/352
(98 %)
0 diff
(100 %id)
BP229351 brain .o 1 to 578 1 to 581 Q34* tiling clone,   581/582
(99 %)
5 diff
(99.2 %id)
BM686500 eye, optic nerve .p 1 to 645 7 to 649   tiling clone,   643/649
(99 %)
8 diff
(98.8 %id)
AW189550 serous papillary carcinoma, high grade, 2pooled tumors, uterus .p 134 to 384 385 to 135       251/385
(65 %)
0 diff
(100 %id)
BI033436 nervous_normal .p 238 to 591 1 to 352       352/352
(100 %)
6 diff
(98.3 %id)
BM824169 Ascites, stomach .p 267 to 803 1 to 537   tiling clone,   537/537
(100 %)
2 diff
(99.7 %id)
BP431751   .p 424 to 781 1 to 359       359/359
(100 %)
4 diff
(98.9 %id)
DB133600 thymus .p 599 to 1164 2 to 567   capped   566/567
(99 %)
2 diff
(99.7 %id)
CX782652 human embryonic stem cells .p 665 to 1163 1 to 499   fully sequenced, AAA   499/499
(100 %)
2 diff
(99.6 %id)
CX782578 human embryonic stem cells .p 726 to 1163 464 to 27   fully sequenced, AAA   438/438
(100 %)
3 diff
(99.4 %id)
BM672732 eye, optic nerve .p 739 to 1168 448 to 19   tiling clone, AAA   430/430
(100 %)
0 diff
(100 %id)
DB078023 testis .q 1 to 574 2 to 575   tiling clone, capped   574/574
(100 %)
0 diff
(100 %id)
CR981881 T-Lymphocytes .q 411 to 1108 1 to 699   tiling clone,   699/699
(100 %)
1 diff
(99.9 %id)
CD514986 White Matter .r-u 1 to 870 1 to 879 exact tiling clone,   879/984
(89 %)
12 diff
(98.8 %id)
CV341282 head_neck .r-u 173 to 779 1 to 609       609/609
(100 %)
27 diff
(95.6 %id)
DB281640 uterus .s 1 to 548 2 to 549   tiling clone, capped   548/548
(100 %)
0 diff
(100 %id)
AW902862 nervous_normal .s 146 to 493 1 to 348       348/348
(100 %)
2 diff
(99.5 %id)
DB352528 uterus .s 1238 to 1801 564 to 1   tiling clone,   564/564
(100 %)
0 diff
(100 %id)
DB037839 testis .t 1 to 578 2 to 579   tiling clone, capped   578/578
(100 %)
0 diff
(100 %id)
BF341980 brain, glioblastoma with EGFR amplification .t 310 to 992 1 to 701 H57Q K58Q V59G K60E T61D ... tiling clone,   698/988
(70 %)
29 diff
(97.1 %id)
BX379431 Placenta Cot 25-normalized .u 1 to 963 1 to 950 E35X L36F Q37S Q38S Y39T ... tiling clone,   950/982
(96 %)
20 diff
(98.0 %id)
BX379430 Placenta Cot 25-normalized .u 1258 to 1814 556 to 1   tiling clone,   556/556
(100 %)
5 diff
(99.2 %id)
CR745935   .va-u 1 to 536 1 to 535   tiling clone,   535/535
(100 %)
2 diff
(99.7 %id)
AA251639 germinal center B cell .va-u 153 to 645 1 to 488 P133L tiling clone, fully sequenced,   488/488
(100 %)
6 diff
(98.8 %id)
AW969318   .va-u 156 to 569 1 to 414 S44X L119R S122F     414/414
(100 %)
2 diff
(99.6 %id)
BG230523 moderate to poorly differentiated invasivecarcinoma, tongue .va-u 309 to 597 292 to 4   tiling clone,   289/292
(98 %)
0 diff
(100 %id)
AI139883   .va-u 571 to 1060 492 to 3   tiling clone,   490/492
(99 %)
0 diff
(100 %id)
AA468903 colon .va-u 599 to 1059 459 to 1   tiling clone,   459/459
(100 %)
15 diff
(96.8 %id)
AA251510 germinal center B cell .va-u 634 to 1059 460 to 39   tiling clone, fully sequenced, AAA   422/422
(100 %)
8 diff
(98.2 %id)
BM153066 leukopheresis .vb 1 to 491 491 to 1 Y82* tiling clone,   491/491
(100 %)
5 diff
(99.0 %id)
BM151745 leukopheresis .vb 73 to 491 420 to 1 V89I     420/422
(99 %)
3 diff
(99.3 %id)
BE246596 leukopheresis .vb 137 to 491 355 to 1   tiling clone,   355/355
(100 %)
7 diff
(98.1 %id)
AA778267 heart .vc 1 to 470 467 to 1 G8V L60C R61G Q62S L63W ... tiling clone,   467/467
(100 %)
7 diff
(98.6 %id)
TI_227714795   .vd 1 to 921 992 to 83 exact tiling clone, AAA   910/988
(92 %)
35 diff
(96.5 %id)
BG215985   .vd 201 to 920 1 to 721 exact tiling clone,   721/776
(92 %)
13 diff
(98.4 %id)
CD742738 Alveolar Macrophage, lung .vd 294 to 921 646 to 19 exact AAA   628/628
(100 %)
0 diff
(100 %id)
TI_57152929   .ve 1 to 678 60 to 732 I46X F81S L82F H83T L84S ...     673/732
(91 %)
8 diff
(99.0 %id)
BI765040 pooled colon, kidney, stomach .ve 3 to 678 1 to 672 I46X F81S L82F H83T L84S ... tiling clone,   672/672
(100 %)
8 diff
(98.9 %id)
F24526 pectoral muscle (after mastectomy) .vf 1 to 356 1 to 356 I2F C10X R69C Q77* tiling clone,   356/356
(100 %)
4 diff
(98.9 %id)
DA521959 brain .vg 1 to 542 2 to 543 exact tiling clone, capped   542/542
(100 %)
0 diff
(100 %id)
AI469483 colon, moderately-differentiated adenocarcinoma .vh 1 to 320 319 to 1   tiling clone,   319/319
(100 %)
3 diff
(99.1 %id)
AW893238 nervous_normal .vh 298 to 549 8 to 257   tiling clone,   250/261
(95 %)
5 diff
(98.1 %id)
AW139526   .vh 509 to 887 396 to 18   tiling clone, AAA   379/379
(100 %)
1 diff
(99.8 %id)
R84533 brain .vi-u 1 to 384 1 to 387   tiling clone,   387/392
(98 %)
8 diff
(98.0 %id)
AI971596 pooled germ cell tumors .vi-u 66 to 612 556 to 10 exact     547/556
(98 %)
0 diff
(100 %id)
BE613834 leiomyosarcoma, uterus .vi-u 73 to 708 1 to 636 exact tiling clone,   636/642
(99 %)
3 diff
(99.6 %id)
AW003177 pooled germ cell tumors .vi-u 152 to 612 470 to 10 exact     461/470
(98 %)
0 diff
(100 %id)
AW594663 pooled germ cell tumors .vi-u 187 to 612 435 to 10 A21X A61G S64F     426/435
(97 %)
0 diff
(100 %id)
BE614441 leiomyosarcoma, uterus .vi-u 277 to 1132 846 to 1   tiling clone,   846/848
(99 %)
18 diff
(97.9 %id)
AI634182 pooled germ cell tumors .vi-u 400 to 612 222 to 10       213/222
(95 %)
0 diff
(100 %id)
CA424828 cell lines, Chondrosarcoma .vi-u 988 to 1588 619 to 19   tiling clone, AAA   601/601
(100 %)
0 diff
(100 %id)
AW594002 pooled germ cell tumors .vi-u 1180 to 1585 418 to 13   AAA   406/406
(100 %)
3 diff
(99.3 %id)
R85926 brain .vi-u 1391 to 1484 94 to 1       94/94
(100 %)
0 diff
(100 %id)
BU902433 leiomyosarcoma, uterus .vj-u 1 to 844 1 to 844 exact tiling clone,   844/844
(100 %)
9 diff
(99.0 %id)
BE244336 leukopheresis .vj-u 248 to 554 1 to 307 E4D L5F A6V V46G V60X tiling clone,   307/307
(100 %)
7 diff
(97.8 %id)
AW081628 colon, moderately differentiated adenocarcinoma .vj-u 632 to 1037 408 to 3       406/408
(99 %)
0 diff
(100 %id)
CD517977 White Matter .vj-u 675 to 1275 29 to 638   tiling clone,   610/1039
(58 %)
14 diff
(98.7 %id)
BX494803 Liver .vj-u 766 to 1345 1 to 580   tiling clone,   580/580
(100 %)
3 diff
(99.5 %id)
BG149257 carcinoid, lung .vj-u 829 to 1366 1 to 538   tiling clone, Submitted on the opposite strand 538/538
(100 %)
2 diff
(99.7 %id)
DB134952 thymus .vk-u 1 to 393 2 to 394 exact tiling clone, capped   393/393
(100 %)
2 diff
(99.5 %id)
AL046396 testis .vk-u 152 to 690 1 to 539       539/541
(99 %)
8 diff
(98.6 %id)
CD656943 Embryonic Stem cells .vk-u 244 to 1070 12 to 835   tiling clone,   824/837
(98 %)
7 diff
(99.2 %id)
DB145648 thymus .vk-u 758 to 1294 2 to 538   tiling clone, capped   537/537
(100 %)
0 diff
(100 %id)
BM906083 ovary (pool of 3) .vl-u 1 to 952 18 to 988 A55S T72N C73V P74S C75V ... tiling clone,   971/1201
(80 %)
34 diff
(97.2 %id)
CV333490 nervous_tumor .vl-u 107 to 298 1 to 192       192/192
(100 %)
1 diff
(99.5 %id)
CV333600 nervous_tumor .vl-u 107 to 298 1 to 193       193/193
(100 %)
9 diff
(95.4 %id)
CA308038 Alveolar Macrophage, lung .vm-u 1 to 662 676 to 16 A7P R8G E9K R10G R11G ... tiling clone, AAA   661/661
(100 %)
8 diff
(98.8 %id)
BQ364395 stomach .vn-u 1 to 534 1 to 536 S18T tiling clone,   536/536
(100 %)
3 diff
(99.5 %id)
AW819562 stomach .vn-u 94 to 543 451 to 2 exact tiling clone,   450/451
(99 %)
0 diff
(100 %id)
D20560   .vn-u 529 to 629 1 to 101   tiling clone, Submitted on the opposite strand 101/103
(98 %)
1 diff
(99.1 %id)
BM151784 leukopheresis .vo 1 to 518 518 to 1 A14X L49C L50W V51X tiling clone,   518/518
(100 %)
3 diff
(99.5 %id)
BM152591 leukopheresis .vo 82 to 518 437 to 1   tiling clone,   437/437
(100 %)
4 diff
(99.1 %id)
BE244169 leukopheresis .vo 122 to 518 397 to 1   tiling clone,   397/397
(100 %)
1 diff
(99.8 %id)
BX119276   .vp-u 1 to 509 1 to 509 exact tiling clone, AAA   509/512
(99 %)
9 diff
(98.3 %id)
AA399600   .vp-u 5 to 480 1 to 474       474/474
(100 %)
4 diff
(99.2 %id)
AA706339 parathyroid gland, parathyroid tumor .vp-u 86 to 508 423 to 1   tiling clone,   423/423
(100 %)
1 diff
(99.8 %id)
AA827125 germinal center B cell .vq-u 1 to 444 454 to 11 exact tiling clone, AAA   444/444
(100 %)
0 diff
(100 %id)
AI057509 liver and spleen .vq-u 28 to 440 413 to 1       413/413
(100 %)
2 diff
(99.6 %id)
AA342975 Spleen .vq-u 131 to 440 310 to 1       310/310
(100 %)
1 diff
(99.7 %id)
CD676692 eye, Trabecular meshwork .vq-u 151 to 442 1 to 292   AAA   292/292
(100 %)
2 diff
(99.4 %id)
AK126524 uterus Gene TTC15, variant not shown       available from FLJ, This clone was ignored    
BG200233   Gene TTC15, variant not shown         This clone was ignored    
F07236 brain, total brain Gene TTC15, variant not shown         This clone was ignored    
Z40344 brain, total brain Gene TTC15, variant not shown         This clone was ignored    
N78637 lung Gene TTC15, variant not shown         This clone was ignored    
W07495 lung Gene TTC15, variant not shown         This clone was ignored    
AA001827 liver and spleen Gene TTC15, variant not shown              
AA002030 liver and spleen Gene TTC15, variant not shown              
AI874381 ovary, tumor, 5 pooled (see description) Gene TTC15, variant not shown              
CA950749 Pancreas, Purified pancreatic islet Gene TTC15, variant not shown       fully sequenced,      
CA950993 Pancreas, Purified pancreatic islet Gene TTC15, variant not shown       fully sequenced,      
CD558076 testis Gene TTC15, variant not shown         This clone was ignored    
DR002486 fetal brain Gene TTC15, variant not shown         This clone was ignored    
DB057481 testis Gene TTC15, variant not shown       capped This clone was ignored    
DB339016 testis Gene TTC15, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m, .n, .o, .p, .q, .r-u, .s, .t, .u, .va-u, .vb, .vc, .vd, .ve, .vf, .vg, .vh, .vi-u, .vj-u, .vk-u, .vl-u, .vm-u, .vn-u, .vo, .vp-u, .vq-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C